王欣之

发布者:韩婧发布时间:2025-03-24浏览次数:154





姓名:王欣之

职称:教授、博士生导师

E-mailxinzhiwang@njucm.edu.cn

主要研究方向:中药(天然药物)抗肿瘤分子机制;中药(天然药物)抗肿瘤新药研发


个人简介

王欣之,教授,博士生导师,中国药科大学天然药物化学博士,美国加州大学伯克利分校劳伦伯克利国家实验室访问学者。主要研究方向为中药(天然药物)抗肿瘤分子机制研究。主持多项国家级、省部级科研项目,以第一或通讯作者身份在 Cancer ResearchActa Pharmaceutica Sinica BeBioMedicineRedox Biology 等国际期刊发表论文30余篇。现任江苏省药学会海洋药物专业委员会委员。


承担的主要科研项目

  1. 国家自然科学基金面上项目,32074067,基于SUMO化修饰调控的中药石蝉草裂木脂素抗KRAS突变型肿瘤的作用机制研究,2021/01-2024/12,主持,55万,结题;

  2. 江苏省高校自然科学重大项目,24KJA360010,盐生中药甜瓜蒂Cucurbitacin B 抑制乳腺癌耐药肺转移的机制研究,2024/07-2027/07,主持,15万,在研;

  3. 江苏省高校自然科学重大项目,19KJA310006,菊芋倍半萜内酯抗白血病干细胞的机制及构效关系研究,时间: 2019/09-2022/09,主持,30万,结题;

  4. 江苏省自然科学基金面上项目,BK20181419,Heliangolides型倍半萜内酯选择性抗白血病干细胞的机制及构效关系研究,2018/07-2022/07,主持,10万,结题;

  5. 国家自然科学基金青年项目,81402812,基于分子对接技术的天然裂木脂素Peperomin E抗肿瘤靶标的寻找及结构优化研究,2015/01-2017/12,主持,23万,结题;

  6. 江苏省自然科学基金青年项目,BK20130954,天然产物Peperomin E诱导胃癌细胞凋亡的机制和结构修饰研究,2013/06-2016/06,20万元,主持,结题。


代表性论文

  1. Xinzhi Wang; Yi Qu; Qianqian Xu; Zeyu Jiang; Hang Wang; Binyan Lin; Zehong Cao; Yuqi Pan; Sheng Li; Yili Hu; Hui Yang; Li He; Hang Chang; Bo Hang; Hongmei Wen; Hao Wu; Jian-Hua Mao; NQO1 Triggers Neutrophil Recruitment and NET Formation to Drive Lung Metastasis of Invasive Breast Cancer, Cancer Research, 2024, 84(21): 3538–55.(中科院1区,IF=12.5

  2. Hui Yang1; Xinzhi Wang1; Adrián Blanco-Gómez; Li He; Natalia García-Sancha; Roberto Corchado-Cobos; Manuel Jesús Pérez-Baena; Alejandro Jiménez-Navas; Pin Wang; Jamie L. Inman; Antoine M. Snijders; David W. Threadgill; Allan Balmain; Hang Chang; Jesus Perez-Losada; Jian-Hua Mao; A Susceptibility Gene Signature for ERBB2-Driven Mammary Tumour Development and Metastasis in Collaborative Cross Mice, eBioMedicine, 2024, 106: 105260.(中科院1区,IF=9.7

  3. Yin Feng; Yefan Han; Anni Hu; Yi Qu; Yili Hu; Hao Wu; Xinzhi Wang*; Li He*; Heliangin Acts as a Covalent Ligand of RPS2 That Disrupts Pre-rRNA Metabolic Processes in NPM1-Mutated Acute Myeloid Leukemia, Acta Pharmaceutica Sinica B, 2023, 13(2): 598–617.(中科院1区,IF=14.8

  4. Anni Hu; Hang Wang; Qianqian Xu; Yuqi Pan; Zeyu Jiang; Sheng Li; Yi Qu; Yili Hu; Hao Wu; Xinzhi Wang*; A Novel CPT1A Covalent Inhibitor Modulates Fatty Acid Oxidation and CPT1A-VDAC1 Axis with Therapeutic Potential for Colorectal Cancer, Redox Biology, 2023, 68: 102959.(中科院1区,IF=10.7

  5. Yefan Han; Anni Hu; Yi Qu; Qianqian Xu; Hang Wang; Yin Feng; Yili Hu; Li He; Hao Wu; Xinzhi Wang*; Covalent Targeting the LAS1-NOL9 Axis for Selective Treatment in NPM1 Mutant Acute Myeloid Leukemia, Pharmacological Research, 2023, 189: 106700.(中科院2区,IF=9.1

  6. Hui Yang1; Xinzhi Wang1; Pin Wang; Li He; Suzyann F. Schick; Peyton Jacob; Neal Benowitz; Lara A. Gundel; Chi Zhu; Yankai Xia; Jamie L. Inman; Hang Chang; Antoine M. Snijders; Jian-Hua Mao; Bo Hang; Thirdhand Tobacco Smoke Exposure Increases the Genetic Background-Dependent Risk of Pan-Tumor Development in Collaborative Cross Mice, Environment International, 2023, 174: 107876.(中科院1区,IF=10.3



  1. Xinzhi Wang; Ming Gao; Jiyun Zhang; Ying Ma; Wenshu Qu; Jingyu Liang; Hao Wu; Hongmei Wen; Peperomin E and Its Orally Bioavailable Analog Induce Oxidative Stress-Mediated Apoptosis of Acute Myeloid Leukemia Progenitor Cells by Targeting Thioredoxin Reductase, Redox Biology, 2019, 24: 101153.(中科院1区,IF=10.7





南中医药学院南中医药学院学子南中医药学院研究生